Ai-ping Zhou
Chinese Academy Of Medical Science And Peking Union Medical College
Beijing, 100021, China
Beijing, 100021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Five-Year Outcomes of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy for Locally Advanced Rectal Cancer: Updated Results of the STELLAR Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 27, 2026
Clinical outcomes of metastatic non-clear cell renal cell carcinoma: a real-world single-centre experience.
Journal: Annals of medicine
Published: January 24, 2026
Fruquintinib plus sintilimab in previously bevacizumab-treated, pMMR/MSS refractory metastatic colorectal cancer: a phase 2 clinical trial.
Journal: Cancer immunology, immunotherapy : CII
Published: August 19, 2025
First-line benmelstobart plus anlotinib versus sunitinib in advanced renal cell carcinoma (ETER100): a multicentre, randomised, open-label, phase 3 trial.
Journal: The Lancet. Oncology
Published: March 18, 2025
Serum IgA as a Prognostic Beacon: Anticipating Systemic Therapy Efficacy in Metastatic Clear Cell Renal Cell Carcinoma.
Journal: Annals of surgical oncology
Published: March 11, 2024
High Expression of Cancer-derived Immunoglobulin G is Associated with Poor Survival in Metastatic Clear Cell Renal Cell Carcinoma.
Journal: European urology open science
Published: January 02, 2024
A single-arm, multicenter, phase 2 clinical study of recombinant humanized anti-HER2 monoclonal antibody-MMAE conjugate (MRG002) in HER2-positive unresectable locally advanced or metastatic urothelial carcinoma.
Journal: European journal of cancer (Oxford, England : 1990)
Published: December 26, 2023
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023.
Journal: Cancer communications (London, England)
Published: December 08, 2023
A phase I trial of autologous RAK cell immunotherapy in metastatic renal cell carcinoma.
Journal: Cancer immunology, immunotherapy : CII
Published: October 26, 2023
Regorafenib monotherapy or combined with an immune-checkpoint inhibitor as later-line treatment for metastatic colorectal cancer: a multicenter, real-world retrospective study in China.
Journal: BMC cancer
Published: September 24, 2023
Prognosis and Clinicopathological Characters of Adult TFEB-Altered Renal Cell Carcinoma: A Single Center Experience of 18 Cases.
Journal: Clinical genitourinary cancer
Published: September 18, 2023
Dynamic alteration and prognostic significance of tumor-associated CD68+ and CD68+ PD-L1- macrophages in muscle-invasive bladder cancer treated with neoadjuvant chemotherapy.
Journal: Cancer medicine
Published: May 06, 2022
Last Updated: 09/26/2026